SOURCE: BIO-key International, Inc

BIO-key International, Inc

July 19, 2012 08:59 ET

BIO-key® International, Inc. Fingerprint Biometric Technology Featured in New IBM® Redguide™ Publication

WALL, NJ--(Marketwire - Jul 19, 2012) -  BIO-key International, Inc. (OTCBB: BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that IBM has made available the first edition of the "BIO-key Biometric Service Provider for IBM Security Access Manager for Enterprise Single Sign-On" Redguide publication detailing how BIO-key's biometric technology can provide advanced authentication and identification solutions for IBM clients. 

IBM Redbooks and Redguide publications are developed and published by IBM. This new IBM Redguide publication is available at

A critical challenge that virtually every organization faces is protecting internal and customer data and making access to the systems and applications that hold that data as convenient as possible.

BIO-key can help organizations meet this challenge. It provides a fingerprint, biometric-enabled sign-on to IBM Security Access Manager for Enterprise Single Sign-On. By using BIO-key Biometric Service Provider, the user simply places a finger on a reader. The fingerprint is then identified and authenticated to enterprise applications and data using IBM Security Access Manager for Enterprise Single Sign-On. The identification and authentication occur within one to two seconds, without the user entering a user ID or password. This more secure, more convenient form of identification is an intuitive, uncomplicated, and easy-to-install alternative to using a password that is too easily forgotten or compromised.

"This is a milestone for our company," stated Mike DePasquale, Chief Executive Officer of BIO-key. "The IBM Redguide publication will be available to thousands of IBM technical sales and support representatives, solution providers, business partners, customers, prospects and posted on the IBM social media outlets; the reach is quite significant. We anticipate that the exposure and awareness generated for BIO-key, by the IBM Redguide publication, will lead to a measureable increase in business opportunities. BIO-key has already started deploying our biometrics along with IBM security offerings at a number of customer sites around the world and expect our revenue to expand in the coming quarters," added DePasquale.

IBM selected BIO-key as one of their biometric partner because of BIO-key's unique ability to offer universal access to any fingerprint reader, any device, such as a PC, laptop, tablet or smartphone and operate on any platform including iOS, Windows Mobile, and Android. No other finger biometric software provider offers this capability.

There have been 354 million privacy breaches over the past five years in the United States alone. To address this issue many companies are migrating to risk based authentication models. IBM and BIO-key are working together to provide alternative solutions to traditional passwords, PINS and tokens in order to provide best in class security for the business enterprise, healthcare providers, government agencies and the consumer.

About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (

BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

Contact Information

  • Contacts:
    BIO-key International, Inc.
    Scott Mahnken